Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology.

Amiodarone has become an important drug for the treatment of supraventricular and ventricular arrhythmias, in short-term inpatient and outpatient settings. It may also have a role in affecting outcome in patients at high risk for arrhythmic events and sudden death; its place among available therapies is being established in clinical trials.

[1]  P. Kowey,et al.  Dose-Ranging Study of Intravenous Amiodarone in Patients With Life-Threatening Ventricular Tachyarrhythmias , 1995 .

[2]  P C Deedwania,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[3]  J. Soler‐Soler,et al.  Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study. , 1996, Journal of the American College of Cardiology.

[4]  M Gent,et al.  Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-Investigators. , 1993, The American journal of cardiology.

[5]  T. Guarnieri,et al.  Intravenous amiodarone for the prevention of atrial fibrillation after open heart surgery: the Amiodarone Reduction in Coronary Heart (ARCH) trial. , 1999, Journal of the American College of Cardiology.

[6]  Bramahn . Singh,et al.  Antiarrhythmic actions of amiodarone: a profile of a paradoxical agent. , 1996, The American journal of cardiology.

[7]  E. Gang,et al.  High dose oral amiodarone loading: electrophysiologic effects and clinical tolerance. , 1992, Journal of the American College of Cardiology.

[8]  R. Sung,et al.  The Role of Intravenous Amiodarone in the Management of Cardiac Arrhythmias , 1997, Annals of Internal Medicine.

[9]  J. Langberg,et al.  Prospective, randomized comparison of conventional and high dose loading regimens of amiodarone in the treatment of ventricular tachycardia. , 1993, Journal of the American College of Cardiology.

[10]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[11]  K. Kamiya,et al.  Cellular electropharmacology of amiodarone. , 1997, Cardiovascular research.

[12]  C. January,et al.  Adverse effects of low dose amiodarone: a meta-analysis. , 1997, Journal of the American College of Cardiology.

[13]  J. Mason Drug therapy: amiodarone , 1987 .

[14]  B. Lown,et al.  Side effects and complications of amiodarone therapy. , 1985, American heart journal.

[15]  F. Morady,et al.  Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. , 1998, The New England journal of medicine.

[16]  H. Greene Randomized antiarrhythmic drug therapy in survivors of cardiac arrest (the CASCADE Study). The CASCADE Investigators. , 1993, The American journal of cardiology.

[17]  P. Kowey,et al.  Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group. , 1995, Circulation.

[18]  Bramahn . Singh,et al.  Amiodarone: The expanding antiarrhythmic role and how to follow a patient on chronic therapy , 1997, Clinical cardiology.

[19]  S. Connolly,et al.  Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT , 1997, The Lancet.

[20]  K. Harjai,et al.  Effects of Amiodarone on Thyroid Function , 1997, Annals of Internal Medicine.

[21]  A. Camm,et al.  Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT , 1997, The Lancet.

[22]  F. Marcus,et al.  Drug interactions with amiodarone , 1983, American heart journal.

[23]  M. Scheinman,et al.  Adverse Effects of Amiodarone , 1998, Pacing and clinical electrophysiology : PACE.

[24]  P. Armstrong,et al.  Amiodarone hepatotoxicity simulating alcoholic liver disease. , 1984, The New England journal of medicine.

[25]  P. Deedwania,et al.  Pulmonary effect of amiodarone in patients with heart failure. The Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy (CHF-STAT) Investigators (Veterans Affairs Cooperative Study No. 320). , 1997, Journal of the American College of Cardiology.

[26]  R. Cappato,et al.  Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators. , 1993, The American journal of cardiology.

[27]  H. Doval,et al.  Randomised trial of low-dose amiodarone in severe congestive heart failure , 1994, The Lancet.